Drug-oxidizing and conjugating non-cytochrome P450 (non-P450) enzymes in cynomolgus monkeys and common marmosets as preclinical models for humans

Y Uno, S Uehara, H Yamazaki - Biochemical pharmacology, 2022 - Elsevier
Many drug oxidations and conjugations are mediated by a variety of cytochromes P450
(P450) and non-P450 enzymes in humans and non-human primates. These non-P450 …

Role of carboxylesterase and arylacetamide deacetylase in drug metabolism, physiology, and pathology

M Nagaoka, Y Sakai, M Nakajima, T Fukami - Biochemical Pharmacology, 2024 - Elsevier
Abstract Carboxylesterases (CES1 and CES2) and arylacetamide deacetylase (AADAC),
which are expressed primarily in the liver and/or gastrointestinal tract, hydrolyze drugs …

Hydrolase activities of cynomolgus monkey liver microsomes and recombinant CES1, CES2, and AADAC

S Honda, T Fukami, T Tsujiguchi, Y Zhang… - European Journal of …, 2021 - Elsevier
The cynomolgus monkey is a nonhuman primate that is often used for pharmacokinetic and
toxicokinetic studies of new chemical entities. Species differences in drug metabolism are …

Molecular and Functional Characterization of N-Acetyltransferases NAT1 and NAT2 in Cynomolgus Macaque

Y Uno, N Murayama, H Yamazaki - Chemical research in …, 2018 - ACS Publications
Arylamine N-acetyltransferases (NATs) are drug-metabolizing enzymes essential for the
metabolism of endogenous substrates and xenobiotics, and their molecular characteristics …

A novel quantification method for serine hydrolases in cellular expression system using fluorophosphonate-biotin probe

A Abdel-Daim, K Ohura, T Imai - European Journal of Pharmaceutical …, 2018 - Elsevier
In the present study, we established a quantitative western blotting method to measure the
expression level of recombinant serine hydrolases based on their catalytic mechanism …

Differences in intestinal hydrolytic activities between cynomolgus monkeys and humans: evaluation of substrate specificities using recombinant carboxylesterase 2 …

Y Igawa, S Fujiwara, K Ohura, T Hirokawa… - Molecular …, 2016 - ACS Publications
Cynomolgus monkeys, used as an animal model to predict human pharmacokinetics,
occasionally show different oral absorption patterns to humans due to differences in their …

Improved Macaca fascicularis gene annotation reveals evolution of gene expression profiles in multiple tissues

T Tan, L Xia, K Tu, J Tang, S Yin, L Dai, P Lei, B Dong… - BMC genomics, 2018 - Springer
Backgrounds Macaca fascicularis (M. fascicularis) is a primate model organism that played
important role in studying human health. It is vital to better understand the similarity and …

Analysis of carboxylesterase 2 transcript variants in cynomolgus macaque liver

Y Uno, Y Igawa, M Tanaka, K Ohura, M Hosokawa… - Xenobiotica, 2019 - Taylor & Francis
Carboxylesterase (CES) is important for the detoxification of a wide range of drugs and
xenobiotics. In this study, the hepatic level of CES2 mRNA was examined in cynomolgus …

mRNA levels of drug-metabolizing enzymes in 11 brain regions of cynomolgus macaques

Y Uno, H Yamazaki - Drug Metabolism and Pharmacokinetics, 2020 - Elsevier
The cynomolgus macaque is an important nonhuman primate species in drug metabolism
studies, in part because of its evolutionary closeness to humans. Cytochromes P450 …

Identification and characterization of a new carboxylesterase 2 isozyme, mfCES2C, in the small intestine of cynomolgus monkeys

K Ohura, Y Igawa, M Tanaka, K Matsumoto… - Drug Metabolism and …, 2020 - ASPET
In contrast to a single human carboxylesterase 2 (CES2) isozyme (hCE2), three CES2
genes have been identified in cynomolgus monkeys: mfCES2A, mfCES2B, and mfCES2C …